C125-0142 Screening compound: N-(1,3-benzothiazol-2-yl)-2-(4-fluorophenyl)-1-(4-methoxyphenyl)-6-oxopiperidine-3-carboxamide

C125-0142 Screening compound: N-(1,3-benzothiazol-2-yl)-2-(4-fluorophenyl)-1-(4-methoxyphenyl)-6-oxopiperidine-3-carboxamide
C125-0142 Screening compound: N-(1,3-benzothiazol-2-yl)-2-(4-fluorophenyl)-1-(4-methoxyphenyl)-6-oxopiperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C125-0142
N-(1,3-benzothiazol-2-yl)-2-(4-fluorophenyl)-1-(4-methoxyphenyl)-6-oxopiperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C125-0142

Molecular Formula

C26H22FN3O3S (C26 H22 FN3 O3 S)

Compound Name

N-(1,3-benzothiazol-2-yl)-2-(4-fluorophenyl)-1-(4-methoxyphenyl)-6-oxopiperidine-3-carboxamide

IUPAC name

N-(13-benzothiazol-2-yl)-2-(4-fluorophenyl)-1-(4-methoxyphenyl)-6-oxopiperidine-3-carboxamide

SMILES

COc(cc1)ccc1N(C(C(CC1)C(Nc2nc(cccc3)c3s2)=O)c(cc2)ccc2F)C1=O

InChI

InChI=1S/C26H22FN3O3S/c1-33-19-12-10-18(11-13-19)30-23(31)15-14-20(24(30)16-6-8-17(27)9-7-16)25(32)29-26-28-21-4-2-3-5-22(21)34-26/h2-13,20,24H,14-15H2,1H3,(H,28,29,32)

InChI Key

WFQICEFUMUJLND-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14720897

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.208

Distribution Coefficient, logD

5.204

Water Solubility, LogSw

-5.09

Polar Surface Area

55.985

Acid Dissociation Constant (pKa)

9.47

Base Dissociation Constant (pKb)

-0.14

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

19.20

C125-0142 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C125-0142 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C125-0142?
Check Price and Availability of C125-0142, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C125-0142 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C125-0142
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C125-0142
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C125-0142 available by request